1. Home
  2. TTI vs LBRX Comparison

TTI vs LBRX Comparison

Compare TTI & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TTI

Tetra Technologies Inc.

N/A

Current Price

$6.01

Market Cap

1.1B

Sector

Energy

ML Signal

N/A

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$38.62

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTI
LBRX
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
TTI
LBRX
Price
$6.01
$38.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$10.88
★ $58.00
AVG Volume (30 Days)
★ 2.2M
313.2K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.22
EPS
★ 0.18
N/A
Revenue
N/A
N/A
Revenue This Year
$6.50
N/A
Revenue Next Year
$9.58
N/A
P/E Ratio
$35.58
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$15.55
52 Week High
$12.54
$50.16

Technical Indicators

Market Signals
Indicator
TTI
LBRX
Relative Strength Index (RSI) 49.87 43.20
Support Level $5.64 $37.99
Resistance Level $6.31 $41.58
Average True Range (ATR) 0.33 2.87
MACD 0.03 -0.39
Stochastic Oscillator 38.89 8.47

Price Performance

Historical Comparison
TTI
LBRX

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Share on Social Networks: